Seeking Alpha

Mike Zaman's  Instablog

Mike Zaman
Send Message
  • Aspen Insurance (AHL) Upgraded By UBS, Intrexon (XON) Surged On Q3 Results 0 comments
    Nov 10, 2013 8:32 PM | about stocks: AHL, XON

    http://static.cdn-seekingalpha.com/uploads/2013/11/10/saupload_ahl.jpg Aspen Insurance Holdings Ltd. (NYSE:AHL)

    AHL stock surged $0.64 (or +1.65%) to $39.51 and 1,486,480 shares exchanged hands on Friday's market activity.

    AHL was upgraded from Neutral to Buy with price target of $46 by brokerage firm UBS.

    AHL recently reported net income after tax of $107.4 million, or $1.43 diluted net income per share, for the third quarter of 2013.

    http://static.cdn-seekingalpha.com/uploads/2013/11/10/saupload_ahl_chart.png

    AHL provides reinsurance and insurance coverage to clients in various domestic and global markets through wholly-owned subsidiaries and offices in Bermuda, France, Germany, Ireland, Singapore, Switzerland, the United Kingdom and the United States.

    More about Aspen Insurance Holdings Ltd. (NYSE:AHL) at www.aspen.co.

    **

    **

    http://static.cdn-seekingalpha.com/uploads/2013/11/10/saupload_xon.jpg Intrexon Corporation (NYSE:XON)

    Shares of XON jumped $1.68 (or +9.52%) to $19.33, after the company reported strong performance in its financial results compared with last year.

    For the third quarter 2013, XON posted total revenues of $6.1 million, an increase of 109.7% compared to $2.9 million in the same period the prior year, and net income attributable to XON of $15.4 million, or $0.15 cents per common share, compared to a net loss of $20.5 million for the third quarter 2012.

    http://static.cdn-seekingalpha.com/uploads/2013/11/10/saupload_xon_chart.png

    XON is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy and the Environment to create biologically-based products that improve the quality of life and the health of the planet. Through the company's proprietary UltraVector(NYSE:R) platform, which delivers unprecedented control over the quality, function, and performance of living cells, XON provides its partners with industrial-scale design and development of complex biological systems. XON calls its synthetic biology approach and integrated technologies Better DNA(R).

    More about Intrexon Corporation (NYSE:XON) at www.dna.com.

    **

    Read Full Disclaimer at www.drstockpick.com/disclaimer

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Back To Mike Zaman's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.